Evidence map›Paper›PMID 38571514›Full record

ArticleReproductive medicine and biology

Identification of long noncoding RNAs downregulated specifically in ovarian high-grade serous carcinoma.

Maki Hayashi-Okada, Shun Sato, Kengo Nakashima, Takahiro Sakai, Tetsuro Tamehisa, Takuya Kajimura, Isao Tamura, Kotaro Sueoka, Norihiro Sugino

Open access · goldAbstract read
In one paragraph

Article in Reproductive medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. LncRNAs signatures in gynecological cancers: ovarian and endometrial cancers.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Maki Hayashi-OkadaDepartment of Obstetrics and Gynecology Yamaguchi University Graduate School of Medicine Ube Japan.
Shun SatoDepartment of Obstetrics and Gynecology Yamaguchi University Graduate School of Medicine Ube Japan.ORCID https://orcid.org/0000-0002-2395-7716
Kengo NakashimaDepartment of Obstetrics and Gynecology Yamaguchi University Graduate School of Medicine Ube Japan.
Takahiro SakaiDepartment of Obstetrics and Gynecology Yamaguchi University Graduate School of Medicine Ube Japan.
Tetsuro TamehisaDepartment of Obstetrics and Gynecology Yamaguchi University Graduate School of Medicine Ube Japan.
Takuya KajimuraDepartment of Obstetrics and Gynecology Yamaguchi University Graduate School of Medicine Ube Japan.
Isao TamuraDepartment of Obstetrics and Gynecology Yamaguchi University Graduate School of Medicine Ube Japan.ORCID https://orcid.org/0000-0002-0737-5556
Kotaro SueokaDepartment of Obstetrics and Gynecology Yamaguchi University Graduate School of Medicine Ube Japan.
Norihiro SuginoDepartment of Obstetrics and Gynecology Yamaguchi University Graduate School of Medicine Ube Japan.ORCID https://orcid.org/0000-0001-8874-7931
Yamaguchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To investigate whether long noncoding RNAs (lncRNAs) are involved in the development or malignant behavior of ovarian high-grade serous carcinoma (HGSC), we attempted to identify lncRNAs specific to HGSC. Methods: Total RNAs were isolated from HGSC, normal ovarian, and fallopian tube tissue samples and were subjected to a PCR array that can analyze 84 cancer-associated lncRNAs. The lncRNAs that were upregulated and downregulated in HGSC in comparison to multiple samples of normal ovary and fallopian tube were validated by real-time RT-PCR. To infer the function, ovarian cancer cell lines that overexpress the identified lncRNAs were established, and the activation of cell proliferation, migration, and invasion was analyzed. Results: Eleven lncRNAs (ACTA2-AS1, ADAMTS9-AS2, CBR3-AS1, HAND2-AS1, IPW, LINC00312, LINC00887, MEG3, NBR2, TSIX, and XIST) were downregulated in HGSC samples. We established the cell lines that overexpress ADAMTS9-AS2, CBR3-AS1, or NBR2. In cell lines overexpressing ADAMTS9-AS2, cell proliferation was suppressed, but migration and invasion were promoted. In cell lines overexpressing CBR3-AS1 or NBR2, cell migration tended to be promoted, although cell proliferation and invasion were unchanged. Conclusion: We identified eleven lncRNAs that were specifically downregulated in HGSC. Of these, CBR3-AS1, NBR2, and ADAMTS9-AS2 had unique functions in the malignant behaviors of HGSC.

Indexed as

ADAMTS9‐AS2CBR3‐AS1HGSClncRNANBR2

Identifiers

PMID38571514
PMCPMC10988898
OpenAlexW4393904488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.